Cancer myths can fuel self-blame, restrictive eating and delayed action on weight loss.
Removing sugar does not stop tumour growth; broad restriction can remove energy, protein, fibre, vitamins and minerals during treatment.
A patient may leave a cancer conversation believing the illness was their fault and that eating less will help treat it.
Cancer nutrition and narrative bias meet at the point where an explanation changes behaviour. One concerns the stories patients and clinicians construct around illness; the other, the dietary claims that gather around treatment. A coherent account is not enough. It also matters what the account makes the patient believe and do.
Patients may attribute cancer to stress, delayed recognition or some personal failure. A clinician can acknowledge the guilt and distress without confirming a causal link that the available facts do not establish. That distinction matters. Empathy requires understanding the patient’s perspective; it does not require agreement with an unsupported explanation.
The same problem becomes more concrete when the story changes eating. Removing sugar does not stop tumour growth. Broad carbohydrate or food-group restriction may instead remove energy, protein, fibre, vitamins and minerals from a patient whose intake is already falling. Food cannot materially alter blood pH, fasting is not recommended during treatment, and high-dose supplements may interfere with chemotherapy.
These conversations can become tense because food is rarely just food in this setting. Family pressure may reflect distress and loss of control, especially when treatment, nausea, pain or surgery has reduced what the patient can manage. A flat correction may win the factual point while leaving the underlying distress untouched. A neutral explanation should make the evidence clear, reduce blame and protect nutrition.
The clinical assessment needs to move quickly from belief to consequence. Ask about appetite, actual intake, weight trend, nausea, pain, swallowing and fatigue. When recent weights are unavailable, tighter belt settings, loose jewellery, more prominent collarbones, reduced activity and withdrawal can reveal decline. Waiting for severe deterioration risks reaching the point where chemotherapy doses are reduced, admission is considered or tube feeding becomes necessary.
The narrative-bias discussion offers a useful discipline for these consultations: keep observed facts, interpretation and uncertainty separate. That makes it possible to say that a claim is unproven without dismissing the person who believes it. It also keeps the practical plan visible: treat reversible symptoms, use regular meals and snacks, fortify food, draw on practical help, and involve the oncology team or a dietitian when warning signs appear.
When a patient with cancer starts fasting, excludes major food groups or loses weight, correct the harmful claim, assess nutritional decline and arrange help before treatment is compromised.
Successful vaccination programmes make the diseases they prevent less visible, which can leave misinformation unchallenged. The practical focus is neutral curiosity, personalised comparison of infection and vaccine risk, a clear recommendation, and routine admission or discharge prompts.
Medication overuse headache should be considered when a previously episodic primary headache occurs on at least 15 days each month. Count treatment days, not tablets: 10 days for triptans, opioids or combination analgesics, and 15 for simple analgesics, sustained for more than three months.
Propensity-matched data from new neurology patients found no overall increase in 90-day follow-up, emergency department attendance, hospitalisation or testing after a virtual first visit. Small differences between presenting complaints support selective use and complaint-level monitoring rather than blanket conclusions
Weight loss, reduced appetite, nausea, pain, dysphagia, fatigue and looser clothing are warning signs during cancer treatment. The discussion challenges sugar restriction, alkaline diets, fasting and high-dose supplements while emphasising food-first support and timely dietetic review.
Clinical stories can aid understanding, but a smooth narrative may conceal missing facts, uncertain causal links or a patient’s self-blame. The useful discipline is to separate chronology, objective findings, interpretation and uncertainty while preserving empathy and professional boundaries.
Ask what belief is driving any major dietary change during cancer treatment, then separate what is known from what remains uncertain. Check appetite, intake, weight trend, nausea, pain, swallowing and fatigue. Arrange oncology or dietetic review when warning signs appear rather than waiting for severe decline.
A patient reports that a common illness began shortly after vaccination and concludes that the vaccine caused it. What communication approach is most appropriate?
Receive the concern neutrally, identify the feared outcome, explain that temporal association alone does not establish causation, compare the risks of infection and vaccination, and make a clear recommendation.
An adult with established migraine has headache on 18 days each month and uses a triptan on 12 days each month for more than three months. Which diagnosis should be considered?
Medication overuse headache. The pattern combines at least 15 headache days each month with triptan use on at least 10 days each month for more than three months.
A patient receiving cancer treatment loses weight, has poor appetite and starts fasting while excluding bread, rice, fruit and dairy products because sugar is believed to feed the tumour. What should management prioritise?
Explain that sugar restriction does not stop tumour growth, assess appetite, intake, weight trend and treatment-related symptoms, and arrange timely oncology or dietetic review. Regular meals, snacks and food-first support are preferred to fasting.
.svg)